AU2513997A - Diagnosis and monitoring of neurological disease - Google Patents

Diagnosis and monitoring of neurological disease

Info

Publication number
AU2513997A
AU2513997A AU25139/97A AU2513997A AU2513997A AU 2513997 A AU2513997 A AU 2513997A AU 25139/97 A AU25139/97 A AU 25139/97A AU 2513997 A AU2513997 A AU 2513997A AU 2513997 A AU2513997 A AU 2513997A
Authority
AU
Australia
Prior art keywords
diagnosis
monitoring
neurological disease
neurological
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU25139/97A
Inventor
Andrew John Hubert Gearing
Karen Margrete Miller
Roderick Pigott
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Publication of AU2513997A publication Critical patent/AU2513997A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96486—Metalloendopeptidases (3.4.24)

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU25139/97A 1996-04-09 1997-04-08 Diagnosis and monitoring of neurological disease Abandoned AU2513997A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9607287.1A GB9607287D0 (en) 1996-04-09 1996-04-09 Diagnosis method
GB9607287 1996-04-09
PCT/GB1997/000975 WO1997038314A1 (en) 1996-04-09 1997-04-08 Diagnosis and monitoring of neurological disease

Publications (1)

Publication Number Publication Date
AU2513997A true AU2513997A (en) 1997-10-29

Family

ID=10791724

Family Applications (1)

Application Number Title Priority Date Filing Date
AU25139/97A Abandoned AU2513997A (en) 1996-04-09 1997-04-08 Diagnosis and monitoring of neurological disease

Country Status (3)

Country Link
AU (1) AU2513997A (en)
GB (1) GB9607287D0 (en)
WO (1) WO1997038314A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9809764D0 (en) * 1998-05-07 1998-07-08 Isis Innovation MMP-9 Gene polymorphisms
WO2000020860A1 (en) * 1998-10-08 2000-04-13 Calbiochem Novabiochem Corporation Diagnostic assay for matrix metalloproteinase 9 and use thereof
US7374886B2 (en) 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
AU771309B2 (en) 1999-04-09 2004-03-18 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker
GB9927576D0 (en) * 1999-11-23 2000-01-19 Univ Birmingham Novel assay
EP2275817A1 (en) * 2000-05-17 2011-01-19 Nederlandse Organisatie voor toegepast -natuurwetenschappelijk onderzoek TNO Proteolytic enzymes in diagnosis of kidney disorders
EP1782068B1 (en) 2004-07-23 2010-04-07 Centre de Recherche Public de la Santé Monitoring heart failure
US10626399B2 (en) 2010-01-28 2020-04-21 The Board Of Trustees Of The Leland Stanford Junior University Methods of treating cognitive symptoms of an aging-associated impairment by modulating C-C chemokine receptor type 3 (CCR3)
US10487148B2 (en) 2010-01-28 2019-11-26 The Board Of Trustees Of The Leland Stanford Junior University Methods and compositions for treating aging-associated impairments
US20160208011A1 (en) 2010-01-28 2016-07-21 The Board Of Trustees Of The Leland Stanford Junior University Ccr3 modulation in the treatment of aging-associated impairments, and compositions for practicing the same
US9161968B2 (en) 2011-04-08 2015-10-20 The Board Of Trustees Of The Leland Stanford Junior University Methods of neuroprotection involving macrophage colony stimulating factor receptor agonists
US10905779B2 (en) 2013-12-09 2021-02-02 The Board Of Trustees Of The Leland Stanford Junior University Methods for screening human blood products comprising plasma using immunocompromised rodent models
EP3079708A4 (en) 2013-12-09 2017-08-30 The Board of Trustees of the Leland Stanford Junior University Methods and compositions for treating aging-associated conditions
DK3307296T3 (en) 2015-06-15 2021-12-13 Univ Leland Stanford Junior TIMP2 FOR USE IN THE TREATMENT OF AGING ASSOCIATED CONDITIONS

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0464147B1 (en) * 1989-03-21 2002-06-26 THE UNITED STATES OF AMERICA as represented by the Secretary UNITED STATES DEPARTMENT OF COMMERCE Matrix metalloproteinase inhibitor peptides
US5324634A (en) * 1992-03-31 1994-06-28 The Research Foundation Of State University Of New York Diagnostic tests measuring gelatinase/inhibitor complexes for detection of aggressive and metastatic cancer
EP0670849B1 (en) * 1992-10-29 2003-08-27 Bayer Corporation Diagnostic assay for latent matrix metalloproteinase no. 9
AU7827794A (en) * 1993-08-12 1995-03-14 Regents Of The University Of California, The Human timp-3
US5641636A (en) * 1994-05-20 1997-06-24 University Of Pennsylvania Method of predicting fetal membrane rupture based on matrix metalloproteinase-9 activity

Also Published As

Publication number Publication date
GB9607287D0 (en) 1996-06-12
WO1997038314A1 (en) 1997-10-16

Similar Documents

Publication Publication Date Title
AU6744798A (en) Health condition monitor and method of use
AU5312496A (en) Partially disposable surgical imaging assembly
AU4349097A (en) Non-invasive imaging of biological tissue
AU3228695A (en) Non-invasive blood analyte sensor
AU2513997A (en) Diagnosis and monitoring of neurological disease
EP0736761A3 (en) Engine diagnostic monitor
GB9624411D0 (en) Diagnosis of prion diseases
AU9086898A (en) Remote monitoring of physiological condition
AU6336096A (en) Non-invasive uterine activity sensor
AU1450997A (en) Physiological movement monitoring
AU4418096A (en) Diagnosis of pancreatitis
IL117146A0 (en) Diagnosis of lung condition
AU2909495A (en) Evaluation of blood coagulation activity
AU7260098A (en) Diagnosis and treatment of phosphatase 0r kinase-related disorders
AU7201696A (en) Method of diagnosing crohn's disease
AU2913397A (en) Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
AU4977496A (en) Human neuronal attachment factor-1
AU4670696A (en) Diagnosis of toxicoinfectious clostridiosis
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU2037800A (en) Diagnosis of human glycosylation disorders
AU6852896A (en) Diagnosis and treatment of neurological disease
AU7143996A (en) Method for the diagnosis of coeliac disease
AU2969795A (en) Video and analog monitoring and diagnosis system
AU4455596A (en) Non-invasive medical sensor
GB9406577D0 (en) Diagnosis and treatment of degenerative disease